Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

WOMENinMOTION: a program to help pregnant women manage pelvic girdle pain

Official title: WOMENinMOTION An Intervention Model for Pelvic Girdle Pain to Acquire Health-promoting Habits in Pregnancy and Prevent Chronic Pain in Women

Run by Vastra Gotaland Region · NCT07158957 · Data updated 2026-11-12

This trial tests a digital, person-centered program to teach pregnant women how to manage pregnancy-related pelvic girdle pain and stay physically active.

More Pelvic Girdle Pain trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment592 (estimated)
SponsorVastra Gotaland Region
Government
Locations2 sites (Gothenburg and 1 other locations)
StatusRecruiting
StartedSeptember 19, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 8, 2025
Trial IDNCT07158957 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women (single pregnancy) with or without pelvic girdle pain who do not have major musculoskeletal surgery, serious neurological disease, or uncontrolled intercurrent illnesses.

Probably not a fit

Patients with prior pelvic or spinal fractures or major pelvic surgery, multiple pregnancy, significant musculoskeletal or nervous-system disease, or serious comorbidities like uncontrolled diabetes or hypertension are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

WOMENinMOTION is a randomized controlled trial comparing a person-centered prevention and intervention program plus usual care to usual care alone for pregnancy-related pelvic girdle pain. The program combines pain education addressing sensory, emotional, and cognitive pain components with motivational support to promote healthful physical activity and daily activity adaptations. Digital materials include instructive exercise videos, guidance on pelvic belt use, and information to reduce worries, with physiotherapist support offered when digital content is insufficient. Participants are pregnant women with or without pelvic girdle pain and are randomized to the intervention or control group at sites in Gothenburg, Sweden.

Why it matters

Potential benefit: If successful, the program could reduce the risk of persistent pelvic pain and help pregnant women maintain lifelong, healthy physical activity habits.

How similar studies have gone: Previous trials combining pain education, exercise, and physiotherapy have shown moderate benefits for pregnancy-related pelvic pain, while fully digital programs remain less thoroughly tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* pregnant women with or without pelvic girdle pain

Exclusion Criteria:

* previous fracture, malignancy or surgical interventions (pelvic floor, spine, pelvis, or hip) or disease of musculoskeletal-or nervous system
* serious intercurrent diseases such as diabetes and high blood pressure.
* multiple pregnancy.

Where it's running

  • Närhälsan Gibraltargatan rehabmottagning
    Gothenburg, Sweden
    Recruiting
  • Närhälsan Eriksberg rehabmottagning
    Gothenburg, Sweden
    Recruiting

Study contacts

  • Principal investigator: Annelie Gutke, PhD, associate professor — Göteborg University
  • Study coordinator: Annelie Gutke, associate professor
  • Email: annelie.gutke@gu.se
  • Phone: 0766185747

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.